Literature DB >> 30838626

Evaluating the Regulation of Cytokine Levels After siRNA Treatment in Antigen-Specific Target Cell Populations via Intracellular Staining.

Rima Kandil1, Daniel Feldmann2, Yuran Xie2, Olivia M Merkel3,4.   

Abstract

RNA interference (RNAi) offers a promising base for therapeutic knockdown of clinically relevant genes. Local delivery routes as well as targeted delivery to specific cell populations have been shown to circumvent several hurdles of successful siRNA delivery in vivo. To evaluate and quantify the treatment effect in a precise way, next to measuring the downregulation on gene and protein levels, it is equally essential to investigate the influence on downstream factors such as generated cytokines. Here, we describe an expressive method to specifically isolate the desired target cells and determine their levels of intracellular cytokines by flow cytometry using the example of murine lungs after pulmonary in vivo transfection with siRNA.Therefore, the lungs of treated mice are harvested and processed into single cell suspensions, in which CD4 positive T cells are marked by antibody-coupled magnetic beads and isolated via magnetic separation. These purified target cells are then fixed and permeabilized, making their intracellular interleukins accessible for staining with fluorescently labeled antibodies. Thus, the cytokine levels and hence the precise influence of the siRNA treatment on intracellular conditions can be measured.

Entities:  

Keywords:  Flow cytometry; GATA-3; Inflammation; Knockdown; Lung; OVA challenged mice; T Cell isolation; cytokines; intracellular staining; siRNA delivery

Mesh:

Substances:

Year:  2019        PMID: 30838626      PMCID: PMC6420053          DOI: 10.1007/978-1-4939-9092-4_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

Review 1.  Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation.

Authors:  A Ray; L Cohn
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  High gradient magnetic cell separation with MACS.

Authors:  S Miltenyi; W Müller; W Weichel; A Radbruch
Journal:  Cytometry       Date:  1990

Review 3.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

4.  Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.

Authors:  William M Gwinn; Jesse M Damsker; Rustom Falahati; Ifeanyi Okwumabua; Ann Kelly-Welch; Achsah D Keegan; Christophe Vanpouille; James J Lee; Lindsay A Dent; David Leitenberg; Michael I Bukrinsky; Stephanie L Constant
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

Review 5.  Pathology of asthma.

Authors:  P K Jeffery
Journal:  Br Med Bull       Date:  1992-01       Impact factor: 4.291

6.  Permeabilization of cell membranes.

Authors:  Maria Célia Jamur; Constance Oliver
Journal:  Methods Mol Biol       Date:  2010

7.  Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo.

Authors:  Tilo Biedermann; Christoph Schwärzler; Günther Lametschwandtner; Gebhard Thoma; Nicole Carballido-Perrig; Julia Kund; Jan E de Vries; Antal Rot; José M Carballido
Journal:  Eur J Immunol       Date:  2002-11       Impact factor: 5.532

8.  Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme.

Authors:  Serdar Sel; Michael Wegmann; Tanja Dicke; Sarper Sel; Wolfgang Henke; Ali O Yildirim; Harald Renz; Holger Garn
Journal:  J Allergy Clin Immunol       Date:  2008-03-05       Impact factor: 10.793

9.  RNA interference: learning gene knock-down from cell physiology.

Authors:  Simone Mocellin; Maurizio Provenzano
Journal:  J Transl Med       Date:  2004-11-22       Impact factor: 5.531

Review 10.  Pulmonary delivery of therapeutic siRNA.

Authors:  Jenny Ka-Wing Lam; Wanling Liang; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2011-02-26       Impact factor: 15.470

View more
  1 in total

Review 1.  T-cell targeted pulmonary siRNA delivery for the treatment of asthma.

Authors:  Tobias W M Keil; Domizia Baldassi; Olivia M Merkel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.